The price of certainty: when is a new therapy good enough?

2021 ◽  
Vol 13 (12) ◽  
pp. 1065-1066
Author(s):  
Jens Fiehler ◽  
Kamil Zeleňák ◽  
Antonia Zapf
Keyword(s):  
1976 ◽  
Vol 36 (03) ◽  
pp. 641-644 ◽  
Author(s):  
K. E Giercksky ◽  
A.-B Otnaess ◽  
E Bjørklid ◽  
H Prydz

2015 ◽  
Author(s):  
Laurence Legeai-Mallet
Keyword(s):  

Circulation ◽  
1997 ◽  
Vol 95 (2) ◽  
pp. 311-312 ◽  
Author(s):  
John P. Cooke ◽  
Philip S. Tsao
Keyword(s):  

2021 ◽  
Author(s):  
Serge Mignani ◽  
Vishwa Deepak Tripathi ◽  
Dheerj Soam ◽  
Rama Pati Tripathi ◽  
Swetarka Das ◽  
...  

2009 ◽  
Vol 30 (5) ◽  
pp. 795-803 ◽  
Author(s):  
Ana I. Vega ◽  
Celia Pérez-Cerdá ◽  
Lourdes R. Desviat ◽  
Gert Matthijs ◽  
Magdalena Ugarte ◽  
...  

Glycobiology ◽  
2020 ◽  
Vol 30 (12) ◽  
pp. 941-969 ◽  
Author(s):  
Krzysztof Mikolajczyk ◽  
Radoslaw Kaczmarek ◽  
Marcin Czerwinski

Abstract N-glycosylation is one of the most important posttranslational modifications of proteins. It plays important roles in the biogenesis and functions of proteins by influencing their folding, intracellular localization, stability and solubility. N-glycans are synthesized by glycosyltransferases, a complex group of ubiquitous enzymes that occur in most kingdoms of life. A growing body of evidence shows that N-glycans may influence processing and functions of glycosyltransferases, including their secretion, stability and substrate/acceptor affinity. Changes in these properties may have a profound impact on glycosyltransferase activity. Indeed, some glycosyltransferases have to be glycosylated themselves for full activity. N-glycans and glycosyltransferases play roles in the pathogenesis of many diseases (including cancers), so studies on glycosyltransferases may contribute to the development of new therapy methods and novel glycoengineered enzymes with improved properties. In this review, we focus on the role of N-glycosylation in the activity of glycosyltransferases and attempt to summarize all available data about this phenomenon.


2009 ◽  
Vol 10 (1_suppl) ◽  
pp. S3-S6 ◽  
Author(s):  
Neil MacGillivray

The paper reviews the work of Dr Thomas Latta who during the cholera epidemic of 1831—32 pioneered the use of intravenous saline infusion in the treatment of cholera. The reaction of the medical profession to this new therapy is described and the reasons for the profession’s failure to acknowledge the importance of this advance is analysed. The reasons why the name of Thomas Latta and his contribution did not survive his death in 1833 are discussed and the contributions of twentieth century scholars in remembering his work are highlighted.


1991 ◽  
Vol 11 (4) ◽  
pp. 299-314 ◽  
Author(s):  
Edward F. McClay ◽  
Kevin Hunger
Keyword(s):  

Sign in / Sign up

Export Citation Format

Share Document